English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, May 2, 2024
Press Releases for Thursday, April 23, 2020
Azabu Insights: Mask Usage in Tokyo Reaches Ninety-Seven Percent And Other Reasons Asian Countries Are Winning Against Coronavirus
23:00 HKT/SGT
Blockchain Holdings Enters into Definitive Agreement for Acquisition of COVID-19 Quarantine Management Product TRACEsafe
21:00 HKT/SGT
Toyota's Yaris Cross Makes World Debut
20:25 HKT/SGT
Blockpass, Liquidstar Integrate Digital Identity for Off-Grid Energy, COVID-19 Relief
18:00 HKT/SGT
康方生物连获大基金青睐 香港嘉华集团入股
16:30 HKT/SGT
康方生物連獲大基金青睞 香港嘉華集團入股
16:29 HKT/SGT
重磅喜讯,基石药业首次递交中国大陆新药上市申请,国家药品监督管理局受理同类首创胃肠道间质瘤精准靶向药avapritinib的两个适应症上市申请
13:47 HKT/SGT
重磅喜訊,基石藥業首次遞交中國大陸新藥上市申請,國家藥品監督管理局受理同類首創胃腸道間質瘤精准靶向藥avapritinib的兩個適應症上市申請
13:46 HKT/SGT
CStone announces acceptance of its first New Drug Application in mainland China by the National Medical Products Administration
13:45 HKT/SGT
LEXUS、GSに特別仕様車“Eternal Touring”を設定
13:30 HKT/SGT
Prance Gold Holdings:グローバルな不確実性に囲まれた絶好の機会
13:00 HKT/SGT
Prance Gold Holdings:グローバルな不確実性に囲まれた絶好の機会
13:00 HKT/SGT
NEC、ベトナム地球観測衛星「LOTUSat-1」を受注
10:00 HKT/SGT
NEC、新型コロナウイルスに対するワクチンの設計に向けて、AIを活用した遺伝子解析の結果を公開
10:00 HKT/SGT
NEC to Provide Vietnam with "LOTUSat-1" Earth Observation Satellite System
09:56 HKT/SGT
NEC Publishes Design Blueprints for SARS-CoV-2 Vaccines Using its Artificial Intelligence Technology
09:46 HKT/SGT
Market Leader in LNG Turbomachinery Controls Awarded Multiple Arctic LNG 2 Contracts
00:00 HKT/SGT
Trintech and The Hackett Group Announce Strategic Partnership to Help Organizations Transform the Close
00:00 HKT/SGT
ACN Search:
CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575